United Capital Financial Advisers, LLC Repligen Corp Transaction History

United Capital Financial Advisers, LLC

  • $19.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$170.78 - $208.42 $32,618 - $39,808
-191 Reduced 12.75%
1,307 $240,000
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $10,046 - $16,310
88 Added 6.24%
1,498 $269,000
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $1,665 - $2,118
-12 Reduced 0.84%
1,410 $224,000
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $196,833 - $256,400
1,422 New
1,422 $201,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email